We found that 4-HMC inhibited the TNF-α-induced expression of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and MMPs in synovial fibroblasts, verifying the therapeutic potential of 4-HMC for RA treatment. The gene discussed is TNF; the disease is rheumatoid arthritis.